Haleon New Zealand Ulc was incorporated on 05 Dec 2014 and issued a business number of 9429041530474. The registered ULTD company has been run by 8 directors: Stephen Bruce Moodey - an active director whose contract started on 13 Jul 2018,
Anish Bharat Patel - an active director whose contract started on 28 Oct 2019,
Gregory Michael Madigan - an inactive director whose contract started on 16 Aug 2018 and was terminated on 02 Jul 2021,
Andrew Roland Jenkin - an inactive director whose contract started on 01 Aug 2019 and was terminated on 31 Oct 2019,
Theresa Puleo Agnew - an inactive director whose contract started on 12 Apr 2018 and was terminated on 31 Jul 2019.
According to our information (last updated on 21 Mar 2024), this company registered 1 address: Level 1, 1.04 , 12 Madden Street, Auckland, Auckland, 1010 (category: registered, physical).
Until 27 Jun 2022, Haleon New Zealand Ulc had been using Level 2 E.2 12 Madden Street, Auckland Central, Auckland as their registered address.
BizDb identified previous aliases for this company: from 05 Dec 2014 to 02 Dec 2019 they were named Glaxosmithkline Consumer Healthcare New Zealand Limited.
A total of 100 shares are allocated to 1 group (1 sole shareholder). Haleon New Zealand Ulc is classified as "Pharmaceutical preparation (human) mfg" (business classification C184130).
Principal place of activity
Level 2 E.2 12 Madden Street, Auckland Central, Auckland, 1010 New Zealand
Previous addresses
Address #1: Level 2 E.2 12 Madden Street, Auckland Central, Auckland, 1010 New Zealand
Registered & physical address used from 05 Mar 2021 to 27 Jun 2022
Address #2: Level 11, 21 Queen Street, Auckland Central, Auckland, 1010 New Zealand
Physical & registered address used from 05 Dec 2014 to 05 Mar 2021
Basic Financial info
Total number of Shares: 100
Annual return filing month: November
Financial report filing month: December
Annual return last filed: 06 Nov 2023
Country of origin: NZ
Shareholder Type | Shareholder Name | Address | Period |
---|---|---|---|
Shares Allocation Number of Shares: 100 | |||
Other (Other) | Gsk New Zealand Holding Company Limited | 12 Feb 2020 - |
Previous Shareholders
Shareholder Type | Shareholder Name | Address | Period |
---|---|---|---|
Other | Glaxosmithkline Consumer Healthcare (overseas) Limited Company Number: 9237639 |
05 Dec 2014 - 12 Feb 2020 |
Ultimate Holding Company
Stephen Bruce Moodey - Director
Appointment date: 13 Jul 2018
ASIC Name: Haleon Australia Pty Ltd
Address: Darlinghurst, Nsw, 2010 Australia
Address used since 22 Dec 2022
Address: Ermington, Nsw, 2115 Australia
Address: Surry Hills, Nsw, 2010 Australia
Address used since 13 Jul 2018
Anish Bharat Patel - Director
Appointment date: 28 Oct 2019
ASIC Name: Haleon Australia Pty Ltd
Address: Ermington, 2115 Australia
Address: Drummoyne Nsw, 2047 Australia
Address used since 28 Oct 2019
Gregory Michael Madigan - Director (Inactive)
Appointment date: 16 Aug 2018
Termination date: 02 Jul 2021
ASIC Name: Glaxosmithkline Consumer Healthcare Australia Pty Ltd
Address: Ermington, New South Wales, 2115 Australia
Address: Croydon North, Victoria, 3136 Australia
Address used since 16 Aug 2018
Andrew Roland Jenkin - Director (Inactive)
Appointment date: 01 Aug 2019
Termination date: 31 Oct 2019
ASIC Name: Glaxosmithkline Consumer Healthcare Australia Pty Ltd
Address: Illawong, Sydney, 2234 Australia
Address used since 01 Aug 2019
Address: Ermington, Sydney, 2115 Australia
Theresa Puleo Agnew - Director (Inactive)
Appointment date: 12 Apr 2018
Termination date: 31 Jul 2019
ASIC Name: Glaxosmithkline Consumer Healthcare Australia Pty Ltd
Address: Ermington, Nsw, 2115 Australia
Address: Hunters Hill, Nsw, 2110 Australia
Address used since 12 Apr 2018
Johann Folscher - Director (Inactive)
Appointment date: 05 Dec 2014
Termination date: 13 Jul 2018
ASIC Name: Glaxosmithkline Consumer Healthcare Australia Pty Ltd
Address: Ermington, New South Wales, 2115 Australia
Address: Ermington, New South Wales, 2115 Australia
Address: Balwyn North, Vic, 3104 Australia
Address used since 05 Dec 2014
Elizabeth Reynolds - Director (Inactive)
Appointment date: 25 May 2015
Termination date: 30 Jun 2018
ASIC Name: Glaxosmithkline Consumer Healthcare Australia Pty Ltd
Address: Turramurra, New South Wales, 2074 Australia
Address used since 28 Oct 2015
Address: Ermington, New South Wales, 2115 Australia
Address: Ermington, New South Wales, 2115 Australia
Vincent Cotard - Director (Inactive)
Appointment date: 05 Dec 2014
Termination date: 08 May 2015
Address: Rose Bay, Nsw, 2029 Australia
Address used since 05 Dec 2014
Bucklands Beach Investments Limited
Level 6, 59 High Street
Maui Finance Limited
Level 10, 34 Shortland Street
Rosenthal Trustee Company Limited
Level 14, 34 Shortland Street
Lzy Trustee Company Limited
Level 1, 2 Princes Street
New Zealand Academic And Learning Institute Limited
Level 29, 188 Quay Street
Rennie Cox Trustees No.7 Limited
Level 15, 126 Vincent Street
Jaychem Industries Limited
Parnell House
Medi-map Limited
203 Queen Street
Ozospa New Zealand Limited
Level 6, 36 Kitchener Street
Robin Pharmaceuticals Limited
Level 4
Schulke New Zealand Limited
Level 14, Pwc Tower, 188 Quay Street
Tafic Consulting Limited
Level 5, 57 Fort Street